Catalog No.
Product Name
Application
Product Information
Citations
-
Drug Impurity
Aripiprazole impurity 10 is a recognized impurity of the antipsychotic agent aripiprazole. It is relevant in the context of drug stability and quality control in pharmaceutical development. This compound is used for analytical purposes in the characterization and quantification of aripiprazole formulations, ensuring the integrity and safety of the active pharmaceutical ingredient. -
Drug Impurity
Haloperidol Impurity 9 is a known impurity of the antipsychotic agent Haloperidol. Its characterization is essential for quality control and regulatory compliance in pharmaceutical research. The identification and quantification of this impurity can aid in understanding the safety and efficacy profiles of Haloperidol, making it crucial for drug development and formulation studies. -
Drug Impurity
Roxithromycin impurity 1 is a characterized impurity associated with Roxithromycin, an azalide antibiotic. It serves as a reference standard for analytical purposes, particularly in the assessment of drug purity and stability. This impurity is essential for quality control and regulatory compliance in pharmaceutical development, contributing to the comprehensive understanding of Roxithromycin's chemical profile. -
Drug Intermediate
Oxanilide (N,N'-Diphenyloxalamide) serves as a crucial intermediate in the synthesis of various quinoline and disulfide derivatives. This compound is utilized in the chemical research field for the development of pharmaceuticals and biologically active molecules. Its versatility makes it an important building block in organic synthesis, particularly in the study of drug design and development. -
Drug Impurity
Terbinafine impurity 8 is a drug impurity associated with terbinafine, an antifungal agent. This compound is utilized in the analysis and quality control of terbinafine formulations, enabling researchers to assess the purity and authenticity of pharmaceutical products. Its characterization is essential for regulatory compliance and the development of stable drug formulations. -
Drug Impurity
Losartan impurity 16, also known as Losartan impurity C, is a known impurity associated with the synthesis of the antihypertensive drug Losartan. This compound serves as an important reference material for quality control in pharmaceutical formulations and ensures the purity and safety of drug products. Its characterization supports compliance with regulatory standards during drug development and manufacturing processes. Researchers can utilize this impurity to understand its impact on the overall quality of Losartan preparations. -
Losartan Impurity
Losartan impurity 14 is a chemical variant of Losartan featuring an azido group in its structure. This compound serves as an important intermediate in synthetic chemistry, allowing for the conversion to an amino compound through the use of organophosphorus reagents. Its application is crucial for research focused on drug synthesis and quality control in the development of Losartan-related pharmaceuticals. -
Drug Impurity
Progesterone impurity 5 is a chemical impurity related to progesterone, primarily identified in the synthesis and quality control of progesterone formulations. This impurity may influence the pharmacological profile and efficacy of progesterone-based therapeutic agents. It is utilized in research applications focused on drug development, formulation stability, and regulatory compliance for hormonal medications. -
Drug Impurity
Rivaroxaban Impurity 8 is an impurity variant associated with the anticoagulant Rivaroxaban. This compound is essential for quality control and analytical assessment in pharmaceutical development. Its characterization aids in understanding the stability and integrity of Rivaroxaban formulations, making it a valuable reference standard in drug impurity research and regulatory compliance. -
Drug Impurity
Palbociclib N-aldehyde is an impurity related to the CDK4/6 inhibitor Palbociclib, functioning primarily by inhibiting cell cycle progression in cancer cells. This compound is crucial for analytical and quality control applications in pharmaceutical research, particularly in studies focused on the purity assessment of Palbociclib formulations. Its presence can provide insights into synthetic pathways and stability, contributing to the overall understanding of drug formulation and efficacy. -
Drug Impurity
Doxycycline impurity 1 is a known impurity associated with the antibiotic doxycycline. It serves as a valuable reference standard for assessing the quality and purity of doxycycline formulations during pharmaceutical development and quality control processes. This reagent is essential for analytical studies aiming to identify and quantify impurities to ensure compliance with regulatory standards. -
Drug Impurity
Rufinamide impurity 4 is a specified impurity associated with Rufinamide, a drug used in the treatment of epilepsy. This compound is primarily utilized for quality control and research applications to assess the purity of pharmaceutical formulations. Its identification and characterization are crucial for ensuring the safety and efficacy of Rufinamide-based therapies. -
Drug Impurity
Pemetrexed impurity 25 is a drug impurity associated with Pemetrexed, a multi-targeted antifolate used primarily in cancer therapy. This compound is relevant for identifying and characterizing impurities in pharmaceutical formulations, ensuring quality control during drug development. Its analysis supports compliance with regulatory standards in the assessment of pharmaceutical integrity and safety. -
Drug Impurity
Edoxaban impurity 13 lithium is a chemical impurity associated with Edoxaban lithium. This impurity is relevant for analytical and quality control studies, as it helps in the assessment of drug purity and the safety profile of pharmaceutical formulations. Its identification and quantification are crucial for ensuring compliance with regulatory standards in drug development and manufacturing processes. -
Drug Impurity
Cetirizine impurity 1 is a characterized impurity of Cetirizine, an antihistamine used to treat allergic reactions. This compound is important for quality control in pharmaceutical formulations of Cetirizine, ensuring the safety and efficacy of the final product. It provides essential insight into the synthetic pathways and purification processes involved in drug production. Researchers can utilize Cetirizine impurity 1 for method development and validation in analytical chemistry studies. -
Drug Impurity
Hydroxychloroquine impurity 4 is a known impurity of hydroxychloroquine, primarily identified during the synthesis and quality control of this anti-malarial and anti-inflammatory compound. Research applications include the assessment of drug purity and stability, as well as studies investigating the pharmacological effects and safety profiles of hydroxychloroquine. This impurity serves as a critical reference for analytical methods and regulatory compliance in pharmaceutical development. -
Drug Impurity
Amodiaquine impurity 2, also known as N-Desethyl amodiaquine hydrochloride, serves as a drug impurity of Amodiaquine. This compound is utilized primarily in quality control and analytical chemistry, particularly for assessing the purity of pharmaceutical formulations containing Amodiaquine. Its characterization is essential for ensuring the safety and efficacy of therapeutic agents during drug development and manufacturing processes. -
Drug Impurity
Edoxaban impurity 20 is a minor impurity associated with the anticoagulant Edoxaban. This compound plays a crucial role in pharmaceutical research, particularly in the analysis and characterization of drug formulations. Its presence is essential for assessing the purity and quality of Edoxaban, ensuring compliance with regulatory standards in drug development and production. -
Drug Impurity
Cetirizine impurity 10, also known as Cetirizine amide, is a specific impurity associated with the antihistamine cetirizine. It is primarily utilized for analytical and quality control purposes in pharmaceutical research, facilitating the assessment of drug purity and stability. This compound serves as a critical standard in identifying and quantifying impurities during the development and manufacturing processes. -
Drug Intermediate
5'-O-DMT-N2-Ibu-2'-OMe-G is a vital intermediate for the synthesis of antisense oligonucleotides, facilitating the construction of sequences that can bind complementarily to target mRNA. This compound effectively inhibits the translation of mRNA, thereby reducing the expression of specific proteins and influencing gene regulation. Its application is significant in research focused on genetic disorders and cancer biology. -
Drug Impurity
Paracetamol impurity 3, also known as p-Chloroacetanilide, is a known impurity associated with the synthesis of Paracetamol. This compound is frequently analyzed in pharmacological studies and quality control assessments to ensure the purity of Paracetamol formulations. Its detection and characterization are crucial for regulatory compliance and the evaluation of pharmaceutical quality. -
Drug Impurity
Salbutamol impurity 3, also known as Salbutamol impurity K, is classified as a drug impurity associated with Salbutamol. This compound is primarily utilized in analytical chemistry for the characterization and quantification of Salbutamol formulations. Its identification is crucial for ensuring the quality and safety of pharmaceutical products containing Salbutamol. -
Drug Impurity
Lamivudine impurity 7 is a characterized impurity of the antiviral agent Lamivudine. This compound is critical for quality control and pharmacological assessments in the development of Lamivudine-based therapies. Its analysis is important for ensuring the purity and safety of pharmaceutical formulations containing Lamivudine, and it serves as an analytical standard in regulatory submissions and research applications. -
Drug Impurity
Azilsartan impurity 21, also known as Desethyl azilsartan medoxomil, is a notable impurity associated with Azilsartan. It serves as a critical reference standard in the analysis of pharmaceutical formulations, particularly for quality control and method validation. This compound can be utilized in research focused on the pharmacokinetics and metabolism of Azilsartan, aiding in the assessment of drug purity and stability in various formulations. -
Drug Impurity
Clindamycin palmitate impurity 5, also known as Clindamycin pentadecanoate, is identified as a drug impurity associated with clindamycin formulations. Its presence may influence the pharmacokinetic profiles and safety assessments of clindamycin-based therapies. This compound is crucial for researchers engaged in drug stability studies, impurity profiling, and formulation development within pharmaceutical and medicinal chemistry contexts. -
Drug Impurity
Clindamycin palmitate impurity 8, also known as Clindamycin 3-palmitate, is a drug impurity associated with the antibiotic clindamycin. This compound serves as a significant analytical reference for quality control and research applications in pharmaceutical development. Its presence may impact the efficacy and safety profiles of clindamycin formulations, making it essential for comprehensive studies on drug composition and stability. -
Drug Impurity
Betamethasone acetate impurity 2 is an impurity associated with Betamethasone acetate, a synthetic corticosteroid with anti-inflammatory and immunosuppressive properties. This compound is utilized primarily in analytical chemistry to assess the purity of Betamethasone acetate formulations. Research applications include quality control and characterization of pharmaceutical products, ensuring compliance with regulatory standards. -
Drug Impurity
Palbociclib impurity 49 is a chemical impurity associated with the drug palbociclib, a selective inhibitor of cyclin-dependent kinases 4 and 6 (CDK4/6). This impurity serves as a key standard for analytical applications in drug development and quality control processes. Its characterization is essential for ensuring the purity and efficacy of palbociclib formulations in preclinical and clinical research. -
Drug Impurity
Citalopram impurity 2, also known as (rac)-Didemethyl citalopram, serves as a known impurity in the synthesis of Citalopram. This chemical compound is relevant for analytical chemists seeking to assess the purity of pharmaceutical preparations and to understand potential degradation products. Its characterization is crucial for quality control in the development of selective serotonin reuptake inhibitors (SSRIs). -
Drug Impurity
Rivaroxaban impurity 21 is a chemical impurity associated with Rivaroxaban, a direct factor Xa inhibitor. This compound can be utilized for analytical purposes in the quality control of pharmaceutical formulations and in research to understand the synthesis and degradation pathways of Rivaroxaban. Its identification and quantification are essential for ensuring the purity and safety of Rivaroxaban-based products. -
Impurity
QS-S2 is an impurity associated with QS-21, a potent adjuvant targeting the innate immune system. Research indicates that QS-21 enhances antigenicity and modulates immune responses, making it valuable in vaccine development and related immunological studies. QS-S2 serves as a critical reference for purity assessments and quality control in research applications involving QS-21. -
Drug Impurity
Azilsartan impurity 27 is characterized as a drug impurity associated with Azilsartan, an antihypertensive agent. This impurity is relevant for analytical research and quality control in pharmaceutical development, particularly in assessing the purity and stability of Azilsartan formulations. Its identification and quantification may provide insights into synthesis methods and help ensure compliance with regulatory standards. -
Drug Impurity
Rivaroxaban impurity 2 is identified as an impurity associated with Rivaroxaban, a direct Factor Xa inhibitor. This compound is primarily utilized in analytical studies to investigate the purity and stability of Rivaroxaban formulations. Its presence may affect the pharmacological profile and safety assessment of Rivaroxaban in therapeutic applications. -
Drug Impurity
Clindamycin palmitate impurity 3 hydrochloride, also known as Clindamycin palmitate sulfoxide hydrochloride, is classified as a drug impurity. This compound is essential for assessing the quality and safety of formulations containing clindamycin. It serves as a valuable reference standard in pharmaceutical research and development, particularly in the analysis and control of drug impurities. -
Drug Impurity
Ketoprofen Impurity 9 is a known impurity of Ketoprofen, a non-steroidal anti-inflammatory drug (NSAID) that primarily targets cyclooxygenase enzymes (COX-1 and COX-2). This compound serves as a valuable reference standard in pharmaceutical research, aiding in the assessment of drug purity and compliance with regulatory standards. Its characterization is crucial for quality control and for understanding the potential impacts of impurities on the therapeutic profile of Ketoprofen. -
Drug Impurity
Rabeprazole impurity 17 is a known impurity related to the proton pump inhibitor Rabeprazole. It serves as a critical compound for analytical studies and quality control in pharmaceutical formulations. This impurity is important for investigating the chemical stability and regulatory compliance of Rabeprazole in drug development processes. -
Drug Impurity
Tamsulosin impurity 9 is a chemical impurity associated with Tamsulosin, a selective alpha-1 adrenergic antagonist. This compound is crucial for assessing the purity and stability of Tamsulosin formulations. It serves as an important reference in pharmaceutical research and development, particularly in the quality control of drug products containing Tamsulosin. -
Drug Impurity
Apixaban impurity 47 is a recognized impurity associated with Apixaban, a direct factor Xa inhibitor. This compound is primarily used in the analysis of drug formulations and quality control processes to assess the purity of Apixaban samples. It is valuable for researchers in pharmacology and toxicology studies focused on anticoagulant drug development and safety evaluation. -
Drug Impurity
Azilsartan impurity 2 is a known impurity of the antihypertensive agent azilsartan, targeting the angiotensin II receptor. This compound is utilized in quality control and method development to ensure the purity and safety of azilsartan formulations in pharmaceutical research. Its characterization is critical for compliance with regulatory standards in drug development. -
Drug Impurity
Levofloxacin impurity 9 is a known impurity of the antibiotic Levofloxacin, primarily serving as a reference standard for analytical applications. This compound is utilized in the quality control and characterization of pharmaceutical formulations to ensure compliance with regulatory guidelines. Its presence and quantification are crucial for assessing the purity and safety of Levofloxacin products in drug development and manufacturing processes. -
Drug Impurity
Betamethasone dipropionate impurity 3 is an identified impurity associated with the corticosteroid Betamethasone dipropionate. This compound can be utilized in analytical studies and quality control processes to assess the purity of pharmaceutical formulations. Understanding the presence and behavior of drug impurities is crucial for ensuring product efficacy and safety in clinical applications. -
Drug Impurity
Methoxyamiodarone impurity 1 is a chemical impurity associated with the compound Methoxyamiodarone. It serves as an important reference standard in drug development and quality control, aiding in the characterization and assessment of the purity of pharmaceutical formulations. This impurity can be utilized in analytical studies to ensure compliance with regulatory guidelines and to facilitate the understanding of the compound's safety and efficacy profile. -
Drug Impurity
Prasugrel impurity 8 maleate is a chemical impurity associated with the synthesis of Prasugrel maleate. It is primarily utilized in analytical chemistry for quality control and regulatory compliance in pharmaceutical development. This compound serves as an important reference standard for assessing the purity and stability of Prasugrel formulations in research settings. -
Drug Intermediate
3,5-Dichloropyridine is a versatile drug intermediate primarily utilized in the synthesis of metal-organic framework (MOF) materials and P2X7 receptor antagonists. With its unique chemical structure, it plays a crucial role in developing new therapeutic agents and materials for various research applications. Its significance in organic synthesis makes it valuable for researchers exploring advancements in pharmacology and material science. -
Drug Intermediate
2-Amino-3-bromo-5-fluoropyridine is a versatile drug intermediate primarily used in the synthesis of fluorinated pyridines. This compound features a bromine and a fluorine substituent on the pyridine ring, enhancing its reactivity and utility in various synthetic pathways. It is significant in medicinal chemistry research for the development of fluorinated compounds with potential pharmaceutical applications. -
Drug Intermediate
rel-(2R,3S,4R,5S)-3-(3-Chloro-2-fluorophenyl)-4-(4-chloro-2-fluorophenyl)-4-cyano-5-(2,2-dimethylpropyl)pyrrolidine-2-carboxylic acid tert-butyl ester serves as a crucial drug intermediate in the synthesis of diverse bioactive compounds. Its unique molecular structure and substitutions enhance its role in pharmacological research. This compound is valuable for studies focused on developing targeted therapies and optimizing lead compounds in medicinal chemistry. -
Drug Impurity
Ibrutinib Impurity 5, also known as (S)-Ibrutinib, is a chemical impurity associated with the drug Ibrutinib. This compound may be utilized in analytical studies to assess the purity and quality of Ibrutinib formulations. Its characterization can aid in understanding potential variations in drug synthesis and enhance the reliability of clinical applications. -
Drug Impurity
Ketoprofen impurity 5, also known as rac Ketoprofen amide, is a detected impurity in the synthesis of Ketoprofen. This compound serves as a valuable reference standard for analytical studies in the quality control of pharmaceutical formulations. Its characterization can enhance the understanding of the compound's synthesis process and assist in the assessment of product purity in drug development applications. -
Drug Intermediate
(S)-9-Hydroxy-8-methoxy-12a,13-dihydro-6H-benzo[5,6][1,4]diazepino[1,2-a]indol-6-one functions as a versatile drug intermediate in organic synthesis. This compound plays a crucial role in the preparation of various bioactive molecules utilized in pharmacological research. Its structural characteristics enable the development of novel therapeutics targeting diverse biological pathways. -
Drug Impurity
Dutasteride Impurity 1 is a chemical impurity derived from Dutasteride, a dual 5-alpha-reductase inhibitor used in the treatment of benign prostatic hyperplasia. This impurity is essential for analytical applications, including method development and validation, stability testing, and quality control in pharmaceutical formulations. Researchers can utilize this compound to assess the purity and efficacy of Dutasteride in various drug development processes.
